Generics 140

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Glibenclamide manufacturers

140 products found

Filters

140 products found

glibenclamide

Tablets 5 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Switzerland
GMP approvals
EU GMP
Manufacturer #17471

Manufacturer usually replies in 8 days

glibenclamide

Tablets 5mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Switzerland
GMP approvals
EU GMP
Manufacturer #16196
The company is committed to providing and addressing healthcare needs as well as delivering patient care services across the globe. Through state of art facility, they have been working for more than 60 years and delivering nothing short of excellent.

Manufacturer usually replies in 10 days

glibenclamide

Tablets 5 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Available for
Distribution only
Manufacturer #2110
A pharmaceutical manufacturer based in the EU that has been active for 50+ years. The company's production lines are GMP-compliant. Key production lines are Rx and OTC. Main therapeutic areas include the cardiovascular system, CNS, and diabetes. Main dosage forms include solid, liquid, semi-solid and injectable forms.

Manufacturer usually replies in 6 days

glibenclamide

Tablets 2.5 mg, 5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Canada
GMP approvals
Canada
Manufacturer #17783
It is a pharmaceutical company that began operations in the 2000s in North America and sells a wide selection of generic pharmaceuticals while continuing to expand its portfolio. They try to deliver accessible solutions for patient safety through continuing innovation such as simpler packaging and important safety features. They are laser-focused on developing cutting-edge solutions to ensure that patients have access to high-quality pharmaceuticals.

Manufacturer usually replies in 9 days

glibenclamide

Tablets 5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Bosnia And Herzegovina
GMP approvals
EU GMP
Comments
Indication - diabetes mellitus type 2
Manufacturer #21530

The company is the largest industrial manufacturer of medicines in western Balkan, operating for more than 70 years.
The manufacturer produces an extensive array of medications for oral, injectable, and topical administration, targeting various bodily systems including the digestive system, metabolism, cardiovascular system, systemic infections, skin health, musculoskeletal system, nervous system, and respiratory system. Additionally, the company specializes in systemic hormone drugs, excluding those related to sex hormones, further diversifying its therapeutic offerings. The manufacturer quality system is fully aligned with international regulations and standards, including Good Manufacturing Practices (GMP), Good Laboratory Practices (GLP), Good Clinical Practices (GCP), as well as guidelines from the European Medicines Agency (EMA) and the World Health Organization (WHO).

Manufacturer usually replies in 4 days

glibenclamide

Tablets 5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #13225
It is an Indian manufacturer that is active in 40+ countries. They are in this line of business for 85+ years. The company has a more than $150 million turnover. The company manufactures and distributes more than 100 APIs and 200 formulations which is responsible for 25000+ SKUs. Quality control and quality assurance are one of the focus areas for the company.

Manufacturer usually replies in 3 days

glibenclamide

Tablets 5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
North Macedonia
GMP approvals
EU GMP
Registered in
North Macedonia
Manufacturer #17662
For over 25 years, the company has been specialty license holders and developers with their own staff working on innovative formulations and presentations. Own-label pharmaceutical, generic, and grocery markets expertise. Own-brand product made in an MHRA-approved facility. Reinvestment in new product development and approvals is ongoing. Export products to the Far East and Asia. Importing from outside the EU is a familiar concept.

Manufacturer usually replies in 6 days

glibenclamide

Tablets 3.5 mg, 5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, TGA
Manufacturer #18120

Manufacturer usually replies in 7 days

glibenclamide + metformin hydrochloride

Tablets 2.5MG/400MG, 5MG/500MG

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, TGA
Manufacturer #18120

Manufacturer usually replies in 7 days

glibenclamide

Tablets 5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, TGA
Manufacturer #18120

Manufacturer usually replies in 7 days

glibenclamide

Tablets 2.5mg, 5mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
EU GMP, SA, UA
Unavailable markets
Costa Rica , Ukraine , Vietnam , Albania , Bosnia And Herzegovina , Kosovo , Serbia , Slovenia
Manufacturer #361

It is a global player with more than half a century of experience. It has more than 4 facilities to operate from. They have marketing and promotion in more than 20 countries. It exports to more than 50 countries. The only motto is to improve the quality of human life and to provide access to reliable, high-quality products for human health worldwide. It is focused to create its own cadres in every country it operates.

Manufacturer usually replies in 9 days

glibenclamide

Tablets 5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Indonesia
GMP approvals
Indonesia
Manufacturer #20628

Manufacturer usually replies in 1 days

glibenclamide

Tablets 2.5 mg, 5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20336

Manufacturer usually replies in 4 days

glibenclamide + metformin hydrochloride

Tablets 2.5 mg + 400 mg, 5 mg + 400 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20336

Manufacturer usually replies in 4 days

glibenclamide

Tablets 5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20084

Manufacturer usually replies in 1 days

glibenclamide

Tablets 2.5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19722

Manufacturer usually replies in 3 days

glibenclamide

Tablets 5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Colombia
GMP approvals
INVIMA
Manufacturer #18590
The company is focused on assurance of the best quality, the search for innovative manufacturing processes, and the permanent commitment to scientific research. The development of each of the production and administrative processes are guided by the philosophy of productivity and effectiveness to achieve the satisfaction of the customers, for which the company has world-class technological models.

Manufacturer usually replies in 1 days

glibenclamide + metformin

Tablets 5 mg + 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18431

Manufacturer usually replies in 1 days

glibenclamide + metformin

Tablets 2.5mg + 500mg, 5mg + 500mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
Argentina
Manufacturer #16388
It develops quality products that remain in force to this day. The primary objective is to allow greater efficiency in medical work, allowing professionals to keep pace with the progress of biochemical and bacteriological methods in the world, for the best diagnosis of diseases. Over time, it has become one of the pharmaceutical companies with more than 100 years of experience in the national market. With high-quality and renowned products.

Manufacturer usually replies in 4 days

glibenclamide

Tablets 5mg; pack size: 30

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Ukraine
GMP approvals
PICS
Manufacturer #9289
A pharmaceutical manufacturer based in Europe that has been active in 30+ countries selling its products in Europe, the Middle East, Africa, CIS, and Asia for 30+ years. The main therapeutic areas include gynecology, cardiology, urology, and antiviral. Key production lines are Rx Main dosage forms include solids, liquids, and injectables. The company's production lines are GMP-compliant.

Manufacturer usually replies in 4 days

Want to view all 140 products? Create your free account today!

Glibenclamide:

Glibenclamide, or also known as glyburide, is a drug used for the effective treatment of type 2 diabetes. It was developed in the 1960s during a cooperative study between the two companies Boehringer Mannheim (now Roche) and Hoechst (now Sanofi-Aventis). Following appraisal, it was approved for medical use in the United States in 1984. Glibenclamide can now be distributed in a cost effective manner as a generic medication in line with other pharmaceutical products which have had their patent expire. As such, it is offered for both sale and wholesale at various price points and under different brand names, including Gliben-J, Daonil, Diabeta, Euglucon, Gilemal, Glidanil, Glybovin, Glynase, Maninil, Micronase and Semi-Daonil. Additionally, glibenclamide manufacturers commonly list it as a combination drug with metformin. Which is sold under brand names, including Bagomet Plus, Benimet, Glibomet, Gluconorm, Glucored, Glucovance, Metglib, and others.

Method of action of glibenclamide:

Glibenclamide belongs to a group of drugs called sulfonylureas which treat type 2 diabetes by augmenting the secretion of insulin in pancreatic beta cells. This is facilitated by the inhibition of regulatory subunits causing cell membrane depolarization, allowing calcium access intracellularly and subsequent stimulation of insulin release. With insulin being the hormone responsible for the regulation of blood sugar by promoting the absorption of glucose from the blood into the liver, fat, and skeletal muscle cells. Conferring effective treatment of type 2 diabetes and associated symptoms such as excessive thirst, dysuria, and lethargies.

Glibenclamide containment and dosage:

Glibenclamide manufacturers and glibenclamide suppliers package the medication in tablet, capsule, or oral suspension form. With one 5mg tablet or capsule typically being prescribed to be taken once a day with breakfast or immediately after. This dose can be adjusted by a medical professional up to a recommended two 15mg doses twice a day. It is best taken alongside participation in exercise and at a consistent time. Liquid suspensions are predominantly used for the treatment of infants, with the dosage adjusted to match.

Glibenclamide on Pipelinepharma:

Due to the generic nature, there exists a wide variety of glibenclamide suppliers, distributors, and manufacturers on the market offering their product for wholesale. Searching on our company Pipelinepharma.com online marketplace currently reveals 28 verified global B2B providers located in countries, including India, Mexico, Turkey, the European Union, Israel, Ukraine, Brazil, Switzerland, Jordan, China, South Korea, Egypt, Argentina, Russian, Kuwait, and Oman. These are trusted manufacturers and distributors which have been verified according to strict quality control by the Pipelinepharma team.

Price of glibenclamide and how to buy:

As with other products, the cost of purchase remains confidential and negotiable online between both B2B parties. However, in certain cases, the manufacturer or wholesaler may have chosen to include a desired price to facilitate an order, if so, this indicated cost per sample will be visible in the Pipelinepharma.com list. As such, this enables a clear route for a buyer looking to source glibenclamide or any other pharmaceutical products from an array of global trusted manufacturers and distributors.